Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Wake Forest University Health Sciences
Wake Forest University Health Sciences
University Hospital, Tours
Centre Oscar Lambret
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
The Netherlands Cancer Institute
The Institute of Molecular and Translational Medicine, Czech Republic
Poitiers University Hospital
Nantes University Hospital
Assistance Publique - Hôpitaux de Paris
University Hospital, Montpellier
Hospices Civils de Lyon
Institut Claudius Regaud
Hospices Civils de Lyon
Groupe Francais De Pneumo-Cancerologie
Hasselt University
University Hospital, Bordeaux
Groupe Francais De Pneumo-Cancerologie
Institut du Cancer de Montpellier - Val d'Aurelle
UNC Lineberger Comprehensive Cancer Center
University of Arkansas
Universitair Ziekenhuis Brussel
Centre Georges Francois Leclerc
Gustave Roussy, Cancer Campus, Grand Paris
Institut du Cancer de Montpellier - Val d'Aurelle
University of Virginia
UNICANCER
Scientific Institute San Raffaele
University Hospital, Toulouse
University Hospital, Toulouse
Assistance Publique Hopitaux De Marseille
Assistance Publique Hopitaux De Marseille
Centre Hospitalier Universitaire de Liege
Genentech, Inc.
Wake Forest University Health Sciences
Centre Hospitalier Universitaire, Amiens
Manchester University NHS Foundation Trust
Assistance Publique Hopitaux De Marseille
University Hospital, Clermont-Ferrand
Centre Chirurgical Marie Lannelongue
Wake Forest University Health Sciences
Hospices Civils de Lyon
University Hospital, Grenoble
Centre Hospitalier Universitaire de Saint Etienne
GlaxoSmithKline
Centre Georges Francois Leclerc
Hellenic Oncology Research Group
Centre Hospitalier Universitaire de Nice
Gustave Roussy, Cancer Campus, Grand Paris
Washington University School of Medicine
Central Hospital, Nancy, France